AI assistant
PULSE BIOSCIENCES, INC. — Director's Dealing 2019
Jun 6, 2019
32093_dirs_2019-06-05_0a4eeb5e-1198-4332-9056-5b15704037c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2019-06-03
Reporting Person: Ebbers Ed (EVP & GM, Dermatology)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-03 | Common Stock | F | 2671 | — | Disposed | 37932 | Direct |
Footnotes
F1: The shares reflected on this Form 4 represent shares surrendered exclusively for the payment of tax obligations as set forth in Mr. Ebbers' previously disclosed June 2018 Restricted Stock Unit grant agreement ("RSU agreement"). Mr. Ebbers has not sold or in any other way disposed of shares in any manner other than pursuant to the contractual provisions of the RSU agreement.
F2: The market close price of $11.51 per share on June 3, 2019 was used to calculate the number of withheld shares.
F3: Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.